PeptidePal - Peptide Tracker vs Blood Sugar - Diabetes App
PeptidePal - Peptide Tracker
Blank Labs LLC
App Store
$13.1K/mo
~$157.8K/yr · 237K installs
VS
Blood Sugar - Diabetes App
QR Code Scanner.
Google Play
$0/mo
~$0/yr · 22.8M installs
Revenue winner
PeptidePal - Peptide Tracker wins
+1314800% vs other
Installs winner
Blood Sugar - Diabetes App wins
+9503% vs other
MAU winner
Blood Sugar - Diabetes App wins
+2766% vs other
Rating winner
PeptidePal - Peptide Tracker wins
+1% vs other
Why PeptidePal - Peptide Tracker is winning
Top 3 reasons - backed by the public App Store / Play Store numbers.
- PeptidePal - Peptide Tracker earns roughly 13148× more per month than Blood Sugar - Diabetes App - $13.1K vs $0.
- Subscription model. PeptidePal - Peptide Tracker runs a $8.99/mo subscription that compounds; Blood Sugar - Diabetes App relies on one-shot IAP or ads.
- More monetization surfaces. PeptidePal - Peptide Tracker runs 9 IAP tiers vs 0 - more chances to convert users at the right price.
→ Find more apps with this revenue gap · Full PeptidePal - Peptide Tracker report
Side-by-side metrics
Bars scale to whichever app is bigger on that row. Green = winner.
PeptidePal - Peptide Tracker
vs
Blood Sugar - Diabetes App
Monthly revenue (est.)?
$13.1K
◀
$0
Annual revenue (est.)
$157.8K
◀
$0
Lifetime installs (est.)
237K
▶
22.8M
Monthly active users (est.)?
61K
▶
1.8M
App Store rating
4.69★
◀
4.63★
Total ratings
2K
▶
53K
US grossing rank
-
=
-
Cheapest monthly sub
$8.99
◀
No sub
IAP tiers detected
9 tiers
◀
0 tiers
- Category
- Health & Fitness
- Price
- Free
- Released
- Apr 23, 2026
- Last updated
- Jun 26, 2026
- File size
- 83.4 MB
- Content rating
- 12+
- Version
- 1.4.4
- Languages
- English
- Category
- Health & Fitness
- Price
- Free
- Released
- Jun 20, 2022
- Last updated
- May 18, 2026
- File size
- -
- Content rating
- Everyone
- Version
- 1.3.6
- Languages
- -
PeptidePal - Peptide Tracker trajectory
Blood Sugar - Diabetes App trajectory
FAQ
Which makes more money, PeptidePal - Peptide Tracker or Blood Sugar - Diabetes App? v
PeptidePal - Peptide Tracker earns about $13.1K per month, while Blood Sugar - Diabetes App earns about $0. That is a ∞× revenue gap (~$13.1K more per month for PeptidePal - Peptide Tracker). Annual revenue: PeptidePal - Peptide Tracker ≈ $157.8K/year, Blood Sugar - Diabetes App ≈ $0/year. Estimates are derived from public App Store / Google Play signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.
Which has more downloads, PeptidePal - Peptide Tracker or Blood Sugar - Diabetes App? v
Blood Sugar - Diabetes App leads with about 22.8M estimated downloads vs 237K for PeptidePal - Peptide Tracker - a 96.0× gap. PeptidePal - Peptide Tracker's App Store downloads are estimated from 2K ratings × the standard 1:75 ratio. Blood Sugar - Diabetes App reports 10,000,000+ installs on Google Play.
Are PeptidePal - Peptide Tracker and Blood Sugar - Diabetes App in the same App Store category on each store and competing for the same money? v
Yes - both apps sit in the Health & Fitness category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.
What in-app purchases and subscription pricing do PeptidePal - Peptide Tracker and Blood Sugar - Diabetes App offer? v
PeptidePal - Peptide Tracker: IAP range 9 tiers detected. Blood Sugar - Diabetes App: no IAP detected on the public listing. PeptidePal - Peptide Tracker runs a "Subscription (~$6.67/mo)" monetization model; Blood Sugar - Diabetes App runs "No App Store revenue (monetizes off-store)". Scraped tier prices and detected subscription pricing drive the bulk of the per-app revenue estimate above.
Which has better ratings, PeptidePal - Peptide Tracker or Blood Sugar - Diabetes App? v
PeptidePal - Peptide Tracker edges ahead with ★ 4.7 vs ★ 4.6 (gap of 0.1 stars). Rating volume: PeptidePal - Peptide Tracker 2K ratings, Blood Sugar - Diabetes App 1K ratings. Higher rating volume = stronger ASO signal even when star averages are close.
How accurate are these PeptidePal - Peptide Tracker vs Blood Sugar - Diabetes App revenue estimates? v
Directional - typically within 2-3× of actual money earned for popular apps. The $13.1K for PeptidePal - Peptide Tracker and $0 for Blood Sugar - Diabetes App are derived from App Store grossing rank / Google Play install ranges, scraped IAP tiers, ratings volume and category benchmarks (Health & Fitness) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.
How do I compare PeptidePal - Peptide Tracker or Blood Sugar - Diabetes App to a different App Store app? v
Use the search box at the bottom of this page or paste any two App Store or Google Play links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.